Congo vs Zimbabwe: Previously treated cases tested for RR-/MDR-TB
Congo
100.0%
in 2024
Zimbabwe
100.0%
in 2024
Congo rank
1st
Zimbabwe rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Congo
- Zimbabwe
How they compare
Congo currently reports 100.0% against 100.0% in Zimbabwe, a difference of 0.0%.
The two have swapped places 1 time across 6 shared years of data; in 2014 it was Congo ahead.
Congo ranks 1st and Zimbabwe ranks 1st of 180 countries.
Across the 2 decades both report, Congo averaged higher in 1 and Zimbabwe in 1.
Head to head by decade
| Decade | Congo | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 51.7% | 48.3% | Congo |
| 2020s | 87.2% | 98.0% | 10.8% | Zimbabwe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Congo or Zimbabwe?
- Congo, at 100.0% against 100.0% in Zimbabwe as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Congo and Zimbabwe?
- 0.0%, with Congo ahead.
- How many years of comparable data are there for Congo and Zimbabwe?
- 6 years are reported by both, from 2014 to 2024.
- How do Congo and Zimbabwe rank globally for previously treated cases tested for rr-/mdr-tb?
- Congo ranks 1st and Zimbabwe ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.